Events

ARC welcomes Jan Griffin, MD, amyloidosis cardiologist at the Medical University of South Carolina. Dr. Griffin will discuss how ATTR affects the heart and explore the evolution of treatments for ATTR-CM. She will cover what the available drugs are, how they work (and how do we know they are working), and what's next on the horizon. The webinar concludes with a Q and A session.    

ARC's Executive Director of Research Kristen Hsu presents the most current updates for the clinical trial landscape, with a focus on ATTR amyloidosis. Kristen will also discuss the direction of future research. The webinar concludes with a Q and A session.